NeuroEM Therapeutics
PrivateLast Round
Series A
Jun 13, 2025
Est. Valuation
$14.3M
Total Funding Raised
$3.65M
Company Overview
NeuroEM Therapeutics is a therapeutic devices company developing a non-invasive, wearable head device that uses transcranial electromagnetic treatment to combat cognitive impairment caused by neurodegenerative conditions like Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroEM Therapeutics Comparables
Compare NeuroEM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognito Therapeutics | 82% | |
| Vielight Inc. | 81% | |
| Grey Matter Neurosciences | 81% | |
NeuroEM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 13, 2025 | ||||
| Grant | Jun 1, 2007 |
Key People
Founding team and executive leadership
NeuroEM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rainwater Charitable Foundation | VC Round |
| Glass Foundation, Inc. | VC Round |
| NIH RADx | Grant |
| Pathfinder Venture Capital | Early Funding |
| Angel Investor Forum | Seed |
| Bluelake Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2025
Monthly visitors increased 48% MoM.
- Jun 13, 2025
$3.3M round led by Bluelake Ventures
NeuroEM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroEM Therapeutics's valuation, stock price, and market status.